Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy.
Exploration (Beijing)
; 2(4): 20210274, 2022 Aug.
Article
en En
| MEDLINE
| ID: mdl-37325609
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Exploration (Beijing)
Año:
2022
Tipo del documento:
Article